Stay updated on Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.

Latest updates to the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record for the Phase 1 Ampion COVID-19 study is displayed with its trial design, outcome measures, eligibility criteria, recruitment status, and study dates.SummaryDifference43%

- Check18 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces updates to NIH websites and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check32 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study page displays a 403 Forbidden error, replacing the usual study details with an access-denied message. The changes insert the 403 content and remove many study-related sections, resulting in an inaccessible study entry.SummaryDifference17%

Stay in the know with updates to Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.